Affinity Asset Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.22M | Sell |
50,000
-50,000
| -50% | -$5.22M | 0.71% | 35 |
|
|
2025
Q1 | $11.7M | Buy |
100,000
+25,000
| +33% | +$2.92M | 1.11% | 17 |
|
|
2024
Q4 | $6.35M | Sell |
75,000
-5,000
| -6% | -$423K | 0.85% | 28 |
|
|
2024
Q3 | $7.19M | Hold |
80,000
| – | – | 0.98% | 31 |
|
|
2024
Q2 | $6.44M | Sell |
80,000
-59,758
| -43% | -$4.81M | 0.74% | 34 |
|
|
2024
Q1 | $11.2M | Buy |
139,758
+89,758
| +180% | +$7.16M | 1.38% | 20 |
|
|
2023
Q4 | $3.98M | Buy |
+50,000
| New | +$3.98M | 0.73% | 34 |
|
|
2023
Q3 | – | Sell |
-12,500
| Closed | -$898K | – | 72 |
|
|
2023
Q2 | $898K | Buy |
+12,500
| New | +$898K | 0.31% | 48 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$1.69M | – | 70 |
|
|
2021
Q2 | $1.69M | Buy |
25,000
+15,000
| +150% | +$1.01M | 0.6% | 32 |
|
|
2021
Q1 | $566K | Hold |
10,000
| – | – | 0.19% | 53 |
|
|
2020
Q4 | $815K | Buy |
+10,000
| New | +$815K | 0.43% | 42 |
|